Epigenetic Modifications Following Noxious Stimuli in Infants

2018 ◽  
Vol 20 (2) ◽  
pp. 137-144 ◽  
Author(s):  
Linda A. Hatfield ◽  
Rebecca K. Hoffman ◽  
Rosemary C. Polomano ◽  
Yvette Conley

Purpose: To recruit healthy full- and preterm infants into genetic research and determine the effectiveness of a noninvasive DNA sampling technique for comparing epigenetic modifications. Background: Noxious stimuli during a vulnerable period of infant neuronal plasticity may trigger long-term epigenetic changes affecting neurodevelopment, pain modulation, and reactivity. Recognizing epigenetic pain findings is problematic because parents are reluctant to enroll newborns into genetic research. Methods: Design: Within-subject change over time candidate-gene DNA methylation association study. Setting/ sample: Urban teaching hospital’s neonatal intensive care unit and newborn nursery. Convenience sample of healthy full- (>37 weeks, n = 6) and preterm (<37 weeks, n = 6) infants. Procedure: Parents participated in a genetic presentation prior to informed consent. Infant buccal saliva was collected after admission to the unit and prior to discharge. Analysis: The methylation pattern at the 5′ end of µ-opioid receptor gene ( OPRM1) was examined. DNA was treated with bisulfite to convert all cytosines to uracil residues, leaving methylated cytosines unchanged. Sequencing of untreated and bisulfite-converted DNA was carried out. The sequences of unconverted and bisulfite-converted DNA were aligned with ClustalW, fidelity of the polymerase chain reaction and the sequencing reaction evaluated, and the methylation pattern identified. Results: Recruitment and assessment of a noninvasive DNA sampling technique for comparing epigenetic modifications were successful; however, infant stress did not produce a change in OPRM1 methylation expression. Relevance: This study established the feasibility of recruiting healthy full-term infants into genetic research and the effectiveness of noninvasive DNA sampling for comparing epigenetic modification in infants.

2019 ◽  
Vol 53 (23-24) ◽  
pp. 1439-1449
Author(s):  
Yamna Karssene ◽  
Raquel Godinho ◽  
Mohsen Chammem ◽  
Berardino Cocchiararo ◽  
Said Nouira ◽  
...  

2019 ◽  
Vol 96 ◽  
pp. 118-123 ◽  
Author(s):  
Yamna Karssene ◽  
Carsten Nowak ◽  
Mohsen Chammem ◽  
Berardino Cocchiararo ◽  
Said Nouira

2000 ◽  
Vol 10 (1) ◽  
pp. 283-294 ◽  
Author(s):  
L. Scott Mills ◽  
John J. Citta ◽  
Kevin P. Lair ◽  
Michael K. Schwartz ◽  
David A. Tallmon

2019 ◽  
Vol 18 (7) ◽  
pp. 504-515
Author(s):  
Divya Goel ◽  
Kaiser Un Nisa ◽  
Mohammad Irshad Reza ◽  
Ziaur Rahman ◽  
Shaikh Aamer

In today’s world, migraine is one of the most frequent disorders with an estimated world prevalence of 14.7% characterized by attacks of a severe headache making people enfeebled and imposing a big socioeconomic burden. The pathophysiology of a migraine is not completely understood however there are pieces of evidence that epigenetics performs a primary role in the pathophysiology of migraine. Here, in this review, we highlight current evidence for an epigenetic link with migraine in particular DNA methylation of numerous genes involved in migraine pathogenesis. Outcomes of various studies have explained the function of DNA methylation of a several migraine related genes such as RAMP1, CALCA, NOS1, ESR1, MTHFR and NR4A3 in migraine pathogenesis. Mentioned data suggested there exist a strong association of DNA methylation of migraine-related genes in migraine. Although we now have a general understanding of the role of epigenetic modifications of a numerous migraine associated genes in migraine pathogenesis, there are many areas of active research are of key relevance to medicine. Future studies into the complexities of epigenetic modifications will bring a new understanding of the mechanisms of migraine processes and open novel approaches towards therapeutic intervention.


Sign in / Sign up

Export Citation Format

Share Document